Echo IQ Limited (EIQ), formerly Houston We Have Limited, focuses on developing artificial intelligence (AI) products specifically for cardiovascular care. The company's Echo IQ platform applies proprietary algorithms and methodologies to analyse echocardiographic measurements. This technology enables the platform to generate risk assessments for patients, aiding healthcare providers in making informed decisions regarding cardiovascular health and treatment strategies. Echo IQ's innovative approach leverages AI to enhance the accuracy and efficiency of cardiovascular diagnostics, marking advancements in patient care within the medical field.